Related Experiment Video
Updated: Aug 6, 2026
08:19
Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry
Published on: May 5, 2022
Mitochondrial myopathies and anaesthesia
1University of Otago, Christchurch School of Medicine and Health Sciences, Department of Anaesthesia, Christchurch, New Zealand. shiptonea@xtra.co.nz
European Journal of Anaesthesiology
|April 2, 2004
Summary
Mitochondrial myopathies, caused by mitochondrial DNA abnormalities, affect multiple organ systems. This review highlights diagnosis, preoperative assessment, and safe anesthetic management for these complex genetic disorders.
Area of Science:
- Neurology
- Genetics
- Anesthesiology
Background:
- Mitochondrial myopathies are a diverse group of genetic disorders.
- They stem from structural and functional mitochondrial abnormalities.
- These conditions impact the nervous system, muscles, and other organs.
Purpose of the Study:
- To present the pathophysiology of mitochondrial myopathies.
- To highlight diagnostic methods and preoperative patient assessment.
- To review anesthetic techniques for safe patient management.
Main Methods:
- Review of existing literature on mitochondrial myopathies.
- Discussion of diagnostic approaches, including genetic considerations.
- Analysis of preoperative metabolic correction and anesthetic strategies.
Main Results:
- Mitochondrial DNA's unique genetic properties influence disease characteristics.
- Accurate diagnosis relies on understanding pathophysiology and genetic factors.
- Safe anesthetic management requires careful preoperative assessment and tailored techniques.
Conclusions:
- Mitochondrial myopathies present complex challenges due to multi-system involvement.
- Effective management necessitates a thorough understanding of the underlying mitochondrial dysfunction.
- This review provides guidance for optimizing anesthetic care in affected patients.
More Related Videos
Related Concept Videos
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:15Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
01:21Skeletal Muscle Relaxants: Adverse Effects
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
01:31Skeletal Muscle Relaxants: Therapeutic Uses
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
01:28Disorders of the Skeletal Muscle
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...